Leo Luznik

Leo Luznik publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Leo Luznik sits on this spectrum.

Leo Luznik D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Leo Luznik sits on this spectrum.

Best Publications

• Haploidentical transplant with posttransplant cyclophosphamide vs matched unrelated donor transplant for acute myeloid leukemia

  Stefan O. Ciurea;Mei Jie Zhang;Andrea A. Bacigalupo;Asad Bashey

  695
  Citations

• Nonmyeloablative bone marrow transplantation from partially HLA-mismatched related donors using posttransplantation cyclophosphamide

  P.V O'Donnell;L Luznik;R.J Jones;G.B Vogelsang

  546
  Citations

• The Biology of Chronic Graft-versus-Host Disease: A Task Force Report from the National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease.

  Kenneth R. Cooke;Leo Luznik;Stefanie Sarantopoulos;Frances T. Hakim

  493
  Citations

• HLA-haploidentical bone marrow transplantation with posttransplant cyclophosphamide expands the donor pool for patients with sickle cell disease.

  Javier Bolaños-Meade;Ephraim J. Fuchs;Leo Luznik;Sophie M. Lanzkron

  457
  Citations

• Immune signature drives leukemia escape and relapse after hematopoietic cell transplantation

  Cristina Toffalori;Laura Zito;Valentina Gambacorta;Michela Riba

  404
  Citations

• Modern approaches to HLA-haploidentical blood or marrow transplantation

  Christopher G. Kanakry;Ephraim J. Fuchs;Leo Luznik

  403
  Citations

• Post-Transplantation Cyclophosphamide for Tolerance Induction in HLA-Haploidentical Bone Marrow Transplantation

  Leo Luznik;Paul V. O'Donnell;Paul V. O'Donnell;Ephraim J. Fuchs

  401
  Citations

• Aldehyde Dehydrogenase Expression Drives Human Regulatory T Cell Resistance to Posttransplantation Cyclophosphamide

  Christopher G. Kanakry;Sudipto Ganguly;Marianna Zahurak;Javier Bolaños-Meade

  393
  Citations

• Comparison of Outcomes of HLA-Matched Related, Unrelated, or HLA-Haploidentical Related Hematopoietic Cell Transplantation following Nonmyeloablative Conditioning for Relapsed or Refractory Hodgkin Lymphoma

  Lauri M. Burroughs;Paul V. O'Donnell;Brenda M. Sandmaier;Barry E. Storer

  352
  Citations

• Multi-Institutional Study of Post-Transplantation Cyclophosphamide As Single-Agent Graft-Versus-Host Disease Prophylaxis After Allogeneic Bone Marrow Transplantation Using Myeloablative Busulfan and Fludarabine Conditioning

  Christopher G. Kanakry;Paul V. O'Donnell;Terry Furlong;Marcos J. De Lima

  332
  Citations

• Risk-stratified outcomes of nonmyeloablative, HLA-haploidentical BMT with high-dose posttransplantation cyclophosphamide

  Shannon R. McCurdy;Jennifer A. Kanakry;Margaret M. Showel;Hua Ling Tsai

  328
  Citations

• Donor B-cell alloantibody deposition and germinal center formation are required for the development of murine chronic GVHD and bronchiolitis obliterans

  Mathangi Srinivasan;Ryan Flynn;Andrew Price;Ann Ranger

  324
  Citations

• Nonmyeloablative HLA-Haploidentical Bone Marrow Transplantation with High-Dose Posttransplantation Cyclophosphamide: Effect of HLA Disparity on Outcome

  Yvette L. Kasamon;Leo Luznik;Mary S. Leffell;Jeanne Kowalski

  314
  Citations

• The European Society for Blood and Marrow Transplantation (EBMT) Consensus Guidelines for the Detection and Treatment of Donor-specific Anti-HLA Antibodies (DSA) in Haploidentical Hematopoietic Cell Transplantation.

  Stefan O. Ciurea;Kai Cao;Marcelo Fernadez-Vina;Piyanuch Kongtim

  269
  Citations

• Outcomes of Nonmyeloablative HLA-Haploidentical Blood or Marrow Transplantation With High-Dose Post-Transplantation Cyclophosphamide in Older Adults

  Yvette L. Kasamon;Javier Bolaños-Meade;Gabrielle T. Prince;Hua Ling Tsai

  268
  Citations

• Increased T follicular helper cells and germinal center B cells are required for cGVHD and bronchiolitis obliterans

  Ryan P Flynn;Jing Du;Rachelle G. Veenstra;Dawn K Reichenbach

  245
  Citations

• NK cell recovery after haploidentical HSCT with posttransplant cyclophosphamide: dynamics and clinical implications

  Antonio Russo;Giacomo Oliveira;Sofia Berglund;Raffaella Greco

  241
  Citations

• Donor CD4+ Foxp3+ regulatory T cells are necessary for posttransplantation cyclophosphamide-mediated protection against GVHD in mice.

  Sudipto Ganguly;Duncan B. Ross;Angela Panoskaltsis-Mortari;Christopher G. Kanakry

  222
  Citations

• Single-agent GVHD prophylaxis with posttransplantation cyclophosphamide after myeloablative, HLA-matched BMT for AML, ALL, and MDS

  Christopher G. Kanakry;Hua Ling Tsai;Javier Bolaños-Meade;B. Douglas Smith

  218
  Citations

• Targeted Rho-associated kinase 2 inhibition suppresses murine and human chronic GVHD through a Stat3-dependent mechanism.

  Ryan Flynn;Katelyn Paz;Jing Du;Dawn K. Reichenbach

  208
  Citations